This transcript has been edited for clarity.
Michelle L. O'Donoghue, MD, MPH: Hi. This is Dr Michelle O'Donoghue, reporting for Medscape. Joining me today is Dr Rachel Bond. She is the systems director for women's cardiovascular health at Dignity Health in Arizona. Thanks for joining me today, Rachel.
Rachel M. Bond, MD: Thank you so much. It's a pleasure to be here.
Pregnancy-Related Risk Factors
O'Donoghue: At this conference, you're going to be talking about the issue of cardio-obstetrics. I'm so glad that this topic is finally getting the attention that it deserves because for far too long, we have not been incorporating obstetrics into a woman's cardiovascular history. Really, it should play a key part.
What are your thoughts about what doctors should be asking patients when they're trying to understand what their cardiovascular risk factors are?
Bond: You're absolutely right, that it's such an exciting time in the world of cardio-obstetrics. I would say, particularly this year, it's so timely with us realizing that cardiovascular disease occurs across the lifespan. We know that a key part during a woman's age is reproductive health, if they do decide to have a child.
With that being said, when it comes to us as cardiologists, in addition to the traditional history that we take, which looks at those traditional risk factors like high blood pressure, high cholesterol, diabetes, and smoking history — things that disproportionately impact more women than men, as an example — we also have to think about cardio-obstetrics and the reproductive health of that particular patient.
COMMENTARY
Pregnancy: The Cardiac Stress Test You Can't Ignore
Michelle L. O'Donoghue, MD, MPH; Rachel M. Bond, MD
DisclosuresMarch 22, 2023
This transcript has been edited for clarity.
Michelle L. O'Donoghue, MD, MPH: Hi. This is Dr Michelle O'Donoghue, reporting for Medscape. Joining me today is Dr Rachel Bond. She is the systems director for women's cardiovascular health at Dignity Health in Arizona. Thanks for joining me today, Rachel.
Rachel M. Bond, MD: Thank you so much. It's a pleasure to be here.
Pregnancy-Related Risk Factors
O'Donoghue: At this conference, you're going to be talking about the issue of cardio-obstetrics. I'm so glad that this topic is finally getting the attention that it deserves because for far too long, we have not been incorporating obstetrics into a woman's cardiovascular history. Really, it should play a key part.
What are your thoughts about what doctors should be asking patients when they're trying to understand what their cardiovascular risk factors are?
Bond: You're absolutely right, that it's such an exciting time in the world of cardio-obstetrics. I would say, particularly this year, it's so timely with us realizing that cardiovascular disease occurs across the lifespan. We know that a key part during a woman's age is reproductive health, if they do decide to have a child.
With that being said, when it comes to us as cardiologists, in addition to the traditional history that we take, which looks at those traditional risk factors like high blood pressure, high cholesterol, diabetes, and smoking history — things that disproportionately impact more women than men, as an example — we also have to think about cardio-obstetrics and the reproductive health of that particular patient.
© 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Pregnancy: The Cardiac Stress Test You Can't Ignore - Medscape - Mar 22, 2023.
Tables
Authors and Disclosures
Authors and Disclosures
Authors
Michelle L. O'Donoghue, MD, MPH
Senior Investigator, TIMI Study Group; Associate Professor of Medicine, Harvard Medical School; Associate Physician, Brigham and Women's Hospital, Boston, Massachusetts
Disclosure: Michelle L. O'Donoghue, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Janssen; Novartis; CVS Minute Clinic
Received research grant from: Merck & Co, Inc.; GlaxoSmithKline; Eisai Inc.; AstraZeneca Pharmaceuticals LP; Janssen Pharmaceuticals; Medicines Company; Amgen
The opinions expressed in this article are solely my own and do not necessarily reflect the views and opinions of Brigham and Women's Hospital.
Rachel M. Bond, MD
Assistant Professor, Department of Internal Medicine, Division of Cardiology, Creighton University School of Medicine, Chandler, Arizona; System Director, Women's Heart Health at Dignity Health in Arizona, Gilbert, Arizona
Disclosure: Rachel M. Bond, MD, has disclosed no relevant financial relationships.